Skip to main content
. Author manuscript; available in PMC: 2019 Dec 31.
Published in final edited form as: Am J Gastroenterol. 2010 Feb 9;105(5):1133–1139. doi: 10.1038/ajg.2010.9

Table 2.

Testing results stratified by concomitant immunosuppressive therapy

HACAs Therapeutic IFX Non-therapeutic IFX Non-interpretable
Concurrent IS (n=69) 10 (14) 33 (48) 22 (32) 4 (6)
No concurrent IS (n=86) 25 (29) 18 (21) 41 (48) 2 (2)

HACAs, human anti-chimeric antibodies; IFX, infliximab; IS, immunosuppressive therapy.